Page last updated: 2024-09-03

glycylglutamine and Leukemia, Myeloid, Acute

glycylglutamine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diehl, V; Fuchs, M; Heck, G; Hermann, K; Herrmann, HJ; Holsing, A; Kremer, G; Scheid, C; Schwenk, A; Söhngen, D; Waldschmidt, D1

Trials

1 trial(s) available for glycylglutamine and Leukemia, Myeloid, Acute

ArticleYear
Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy.
    Nutrition (Burbank, Los Angeles County, Calif.), 2004, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dipeptides; Double-Blind Method; Female; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Parenteral Nutrition, Total; Prospective Studies

2004